<code id='8BACB495F0'></code><style id='8BACB495F0'></style>
    • <acronym id='8BACB495F0'></acronym>
      <center id='8BACB495F0'><center id='8BACB495F0'><tfoot id='8BACB495F0'></tfoot></center><abbr id='8BACB495F0'><dir id='8BACB495F0'><tfoot id='8BACB495F0'></tfoot><noframes id='8BACB495F0'>

    • <optgroup id='8BACB495F0'><strike id='8BACB495F0'><sup id='8BACB495F0'></sup></strike><code id='8BACB495F0'></code></optgroup>
        1. <b id='8BACB495F0'><label id='8BACB495F0'><select id='8BACB495F0'><dt id='8BACB495F0'><span id='8BACB495F0'></span></dt></select></label></b><u id='8BACB495F0'></u>
          <i id='8BACB495F0'><strike id='8BACB495F0'><tt id='8BACB495F0'><pre id='8BACB495F0'></pre></tt></strike></i>

          fashion

          fashion

          author:fashion    Page View:8287
          Optum
          Mark Lennihan/AP

          UnitedHealth Group and Optum are getting rid of the name of their tech-driven care management company just months after the company faced congressional criticism over the use of its algorithms to cut off payments for patients’ care.

          Discontinuing the NaviHealth name is part of a broader rebranding of Optum’s division that provides services to people at home and in post-acute facilities. The move also encapsulates how UnitedHealth is pushing to control every piece of patient care outside of the hospital and distancing itself from the aspects that have generated controversy.

          advertisement

          Starting in the first quarter of 2024, Optum’s post-acute-care companies will be called Home & Community Care, according to internal documents obtained by STAT. However, Optum advised employees that “Home & Community Care should not be directly next to the Optum logo” in marketing materials.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds
          Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

          AdobeTheFoodandDrugAdministrationsaidMondaythatithasdeepreservationsaboutNurOwn,aninvestigationalALS

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          EpiPen alternative approval delay highlights citizen petition issue

          AlexWong/GettyImagesAmericanswhosuffersevereallergicreactionswon’thavealternativestoauto-injectorsli